AzTrials
AzTrials

Depressive SymptomsFSSNCT05836090

Family Spirit Strengths

A study testing Family Spirit Strengths (FSS) and Family Spirit Nurture in people with Depressive Symptoms and Anxiety Disorders and Symptoms, run by Johns Hopkins Bloomberg School of Public Health at 3 sites in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This project addresses the disproportionate morbidity and mortality associated with mental and behavioral health problems in American Indian and Alaska Native communities. Access to culturally competent and effective behavioral health services is limited in many of these communities. Read more about this study

Who is it for?
Ages 14 years and older, women only
What is being tested?
Family Spirit Strengths (FSS) and Family Spirit Nurture
Could I receive a placebo?
No, everyone receives an active treatment
How many people
188 participants
Where
3 sitesUnited States
Study dates
20 Apr 2023to 30 Jun 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 14 years and older
  • Women only
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Self-identify as female; and
  • Pregnant or be a primary caregiver of a child that is 24 months or younger; and
  • 14 years or older at time of enrollment; and
  • Report a family history of high-risk substance use and/or report high-risk levels of personal substance use; and
  • Have elevated symptoms of depression and/or anxiety and/or risk of substance use disorder; and
  • Be part of the service population of one of the participating sites.

Who cannot join

  • Profound disability that limits the ability to participate in assessments or interventions; and
  • Unlikely to be residing in or near the research service area for the next 6 months.

Trial locations and contacts

3 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Emily Haroz, PhD contact

410-449-0051

eharoz1@jhu.edu

Leonela Nelson, MPH contact

505-368- 4234

lnelso32@jhu.edu

United States3 sites, 3 recruiting
  • Johns Hopkins Center for Indigenous Health

    Chinle, Arizona, 86503

    Brandy Begay, 928-674-6824, bbegay4@jh.edu

    Recruiting
  • Pokagon Health Services

    Pokagon, Michigan, 49047

    Elizabeth Leffler, 269-462-4406, Elizabeth.Leffler@pokagonband-nsn.gov

    Recruiting
  • Johns Hopkins Center For Indigenous Health

    Shiprock, New Mexico, 87420

    Leonela Nelson, MPH, lnelso32@jhu.edu

    Recruiting

Other trials in United States

About this study

This project addresses the disproportionate morbidity and mortality associated with mental and behavioral health problems in American Indian and Alaska Native communities. Access to culturally competent and effective behavioral health services is limited in many of these communities. The investigators aim to address this gap by testing the effectiveness of a trans-diagnostic secondary prevention program, Family Spirit Strengths (FSS) that can be embedded within home visiting services. The FSS program is a skills-based program that incorporates elements of evidence-based practice, the Common Elements Treatment Approach (CETA), and materials informed and developed based on an Indigenous advisory group. The FSS program aims to help participants build self-efficacy and coping skills, as well as build stronger connections to others, the participants' community, and cultural resources. The investigators will use a randomized controlled trial, whereby half of the participants will receive FSS and the other half will receive an evidence-based nutrition education program. The investigators' study is grounded in participatory processes and led by a team of Indigenous and allied researchers.

Being tested
Family Spirit Strengths (FSS), Family Spirit Nurture
Medical subject headings
Depression, Anxiety Disorders, Substance-Related Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Family Spirit Strengths (FSS)Behavioural

    The FSS intervention consists of psychoeducational components that emphasize the importance of mental and emotional health as part of overall wellness, and seek to normalize experiences of stress, to de-stigmatize help-seeking, and to build hope. Core content focuses on awareness of the connections between thoughts, feelings, behaviors, and spirituality, and imparts related self-help skills. It also specifically builds in connection to culture, land and others as coping strategies. The FSS lessons were developed based on culturally adapting the Common Elements Treatment Approach (CETA).

  • Family Spirit NurtureBehavioural

    The active control Family Spirit Nurture, is an evidence-based nutrition education curriculum that has been previously tested with Navajo communities which focuses on age-appropriate parental feeding practices, including snack routines, avoidance of sugar-sweetened beverages (SSB) and promotion of water consumption.

Study groups in NCT05836090
Study groupRoleWhat they receive
Family Spirit Strengths (FSS)ExperimentalFSS participants will receive 4-16 (average of 6-8) intervention visits covering topics related to their mental and behavioral health. The number of sessions each participant receives varies and depends on their unique needs. To guide this process, all intervention participants will take a brief, in-session survey to screen for current challenges they may be facing. Their answers will help determine the content and dose of future sessions.
Receives: Behavioral: Family Spirit Strengths (FSS)
Family Spirit NurtureActive comparatorParticipants enrolled in nutrition education comparison group will receive 6 educational lessons related to promoting early childhood healthy growth. Lessons will be delivered bi-weekly for no longer than 4-months total. The lessons are from the evidence-based Family Spirit Nurture curriculum.
Receives: Behavioral: Family Spirit Nurture

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Difference in number of poor mental health days in last 30 days as assessed by a single item on the Health-Related Quality of Life (HRQOL) measure

    As measured by the single item on the Health-Related Quality of Life (HRQOL) which asks responders to identify how many days in the past 30 day they experience bad or poor mental health. Scores may range from 0-30 where 0 indicates the participant did not experience any poor mental health days in the last 30 days and 30 indicates the participant experienced a poor mental health day every day in the last 30 days. A difference in mean for the past 30 days will be calculated at the 6 month follow-up timepoint.

    Measured: baseline, 6-9 months post baseline

Secondary outcomes (6)
  1. Days of alcohol or drug use measured by adapted Timeline Follow-Back (TLFB)

    The adapted TLFB records daily substance use during the past 2 weeks. The outcome is the number of days with any alcohol, cannabis, or other drug use, including recreational use of prescription medication (0-14 days). Each day counts once regardless of the number of substances used. Higher values indicate more days of use. The questionnaire also collects alcohol quantities and nicotine use.

    Measured: baseline, 3-6 months post baseline, 6-9 months post baseline

  2. Change in depressive symptoms as measured by the Centers for Epidemiological Research Revised 10 item scale (CESDR-10)

    Centers for Epidemiological Research Revised 10 item scale (CESDR-10). This 10-item screening measure is used to identify individuals who are at high-risk for major depressive disorder. It asks respondents to rate the frequency of specific depressive symptoms in the past two weeks. The more often depressive symptoms that are experienced by the respondent and the more depressive symptoms they experience in general, the higher the risk for major depressive disorder. The average score range for this measure is 0-3. An average score of 0.80 and over is considered high risk and warrants a referral for additional support. A score lower than 0.80 is considered at lower risk and no referral is necessary.

    Measured: baseline, 3-4 months post baseline, 6-9 months post baseline

  3. Change in anxiety symptoms as measured by the Patient-Reported Outcomes Measurement Information System (PROMIS) short form

    Patient-Reported Outcomes Measurement Information System (PROMIS) short form. This 8-item anxiety screening tool asks respondents to rate how often they feel anxiety symptoms in the past 7 days. Items focus on feeling fearful, anxious, worried, nervous, uneasy, tense, and unable to focus on anything other than anxiety. The more often anxiety symptoms are experienced by the respondent and the more anxiety symptoms they experience in general, the higher the risk for an anxiety disorder. The average score range for this measure is 1-5. An average score of 2.125 and above is considered high risk, warrants a referral for additional support. Scores lower than 2.125 average score are considered at lower risk and no referral is necessary.

    Measured: baseline, 3-6 months post baseline, 6-9 months post baseline

  4. Difference in number of poor mental health days in last 30 days as assessed by a single item on the Health-Related Quality of Life (HRQOL) measure

    As measured by the single item on the Health-Related Quality of Life (HRQOL) which asks responders to identify how many days in the past 30 day they experience bad or poor mental health. Scores may range from 0-30 where 0 indicates the participant did not experience any poor mental health days in the last 30 days and 30 indicates the participant experienced a poor mental health day every day in the last 30 days. A difference in mean for the past 30 days will be calculated at the 6 month follow-up timepoint.

    Measured: baseline, 3-4 months post baseline

  5. Alcohol involvement measured by the adapted Alcohol, Smoking and Substance Involvement Screening Test (ASSIST)

    The alcohol score is the mean of 6 items assessing frequency of use, desire to use, problems related to use, failure to meet obligations, concern expressed by others, and unsuccessful efforts to reduce use. Items on use, desire, problems, and obligations refer to the past month. The last 2 distinguish never, within the past month, and before the past month. Scores range from 0 to 6.5, with higher scores indicating greater alcohol involvement. Analysis includes participants reporting alcohol use at baseline.

    Measured: Baseline; post-intervention (3-4 months after baseline); final follow-up (6- 9 months).

  6. Drug involvement measured by the adapted Alcohol, Smoking and Substance Involvement Screening Test (ASSIST)

    The drug score is the mean of 6 parallel items about illegal drugs or legal drugs used other than as prescribed. Drug types are assessed together. Items on use, desire, problems, and obligations refer to the past month. Concern expressed by others and unsuccessful efforts to reduce use distinguish never, within the past month, and before the past month. Scores range from 0 to 6.5, with higher scores indicating greater drug involvement. Analysis includes participants reporting drug use at baseline.

    Measured: Baseline; post-intervention (3-4 months after baseline); final follow-up (6- 9 months).

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 May 2023
  2. Study start20 Apr 2023
  3. Primary completion30 Mar 2028 (estimated)
  4. Study completion30 Jun 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
188 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05836090
Sponsor's protocol ID
IRB00023017
Acronym
FSS
Status last verified
Oct 2026
First submitted
18 Apr 2023
Last updated
19 Oct 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Nelson L, Lopez LM, Archuleta S, Van Wyk SS, Kushman E, Martin L, Mitchell K, Leffler E, Werwie TR, Kemp CG, Cuddy RF, Haroz EE. Testing the effectiveness of Family Spirit Strengths (FSS) - a culturally informed intervention designed to prevent mental health and substance misuse for indigenous families through home visiting. BMC Public Health. 2026 Feb 26;26(1):1085. doi: 10.1186/s12889-026-26593-0.

    PubMed 41749230

Questions about this trial

What is this clinical trial studying?

A study testing Family Spirit Strengths (FSS) and Family Spirit Nurture in people with Depressive Symptoms and Anxiety Disorders and Symptoms, run by Johns Hopkins Bloomberg School of Public Health at 3 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 19 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Emily Haroz, PhD (410-449-0051, eharoz1@jhu.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Difference in number of poor mental health days in last 30 days as assessed by a single item on the Health-Related Quality of Life (HRQOL) measure (time frame: baseline, 6-9 months post baseline). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05836090, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in